Actively Recruiting
Identifying and Characterizing Preclinical MS
Led by Yale University · Updated on 2025-11-14
1000
Participants Needed
1
Research Sites
575 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
R
Roche-Genentech
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research study is to try and identify risk factors and biologic changes that suggest that someone may go on to develop multiple sclerosis before a person has shown any symptoms of the disease.
CONDITIONS
Official Title
Identifying and Characterizing Preclinical MS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- Having at least one risk factor for multiple sclerosis, including:
- Radiologically isolated syndrome
- Family history of multiple sclerosis in a first-degree relative
- Personal risk factors such as smoking, obesity, Epstein Barr virus infection, Vitamin D deficiency, or genetic risk score
You will not qualify if you...
- Currently pregnant
- Diagnosis of multiple sclerosis or any ongoing systemic autoimmune disease
- Currently receiving treatment with immunosuppressive medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yale University
North Haven, Connecticut, United States, 06473
Actively Recruiting
Research Team
E
Erin Longbrake, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here